Evidence map›Paper›PMID 40301229›Full record

ReviewCancer metastasis reviews2025

Metal-modulated T cell antitumor immunity and emerging metalloimmunotherapy.

Peiyun Liao, Ying Zhou, Yingqi Qiu, Rong Hu, Hongyan Li, Hongzhe Sun, Yuhua Li

Abstract readReview
PubMed Publisher
In one paragraph

Review in Cancer metastasis reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Peiyun LiaoDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Ying ZhouDepartment of Chemistry, CAS-HKU Joint Laboratory of Metallomics On Health and Environment, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Yingqi QiuDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Rong HuDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Hongyan LiDepartment of Chemistry, CAS-HKU Joint Laboratory of Metallomics On Health and Environment, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Hongzhe SunDepartment of Chemistry, CAS-HKU Joint Laboratory of Metallomics On Health and Environment, The University of Hong Kong, Pokfulam, Hong Kong SAR, China. hsun@hku.hk.
Yuhua LiDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China. liyuhua1974@outlook.com.

Funding

Basic and Applied Basic Research Foundation of Guangdong Province [2024A1515011659]National Natural Science Foundation of China [82270233, U2001224]
6 · The paper itself

Abstract

In recent years, increasing evidence has shown that metals play important roles in both innate and adaptive immunity. An emerging concept of metalloimmunotherapy has been proposed, which may accelerate the development of immunotherapy for cancers. Here, we discuss how metals affect T cell function through different signaling pathways. Metals impact the fate of T cells, including their activation, proliferation, cytotoxicity, and differentiation. Most importantly, metals also participate in mitochondrial operation by regulating energy production and reactive oxygen species homeostasis in T cells. We also identified the metal-based mutual effects between tumor cells and T cells in the tumor microenvironment. Overall, the antitumor effect of T cells can be improved by targeting metal metabolism and metalloimmunotherapy, which will be a step forward in the treatment of cancers.

Indexed as

ImmunotherapyMetalsNeoplasmsT-LymphocytesAnimalsHumansTumor MicroenvironmentMetalsImmunomodulationMetal ionMetalloimmunotherapyT cellTumor microenvironment

Identifiers

PMID40301229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.